| Literature DB >> 22775484 |
Jong-Yi Park1, Mi-Ryung Park, Hong-Thuy Bui, Deug-Nam Kwon, Min-Hui Kang, Mihye Oh, Jae-Woong Han, Ssang-Goo Cho, Chankyu Park, Hosup Shim, Hye-Min Kim, Man-Jong Kang, Jin-Ki Park, Jeong-Woong Lee, Kyung-Kwang Lee, Jin-Hoi Kim.
Abstract
In this study, we examined whether Hanganutziu-Deicher (H-D) antigens are important as an immunogenic non-α1,3-galactose (Gal) epitope in pigs with a disrupted α1,3-galactosyltransferase gene. The targeting efficiency of the AO blood genotype was achieved (2.2%) in pig fibroblast cells. A total of 1800 somatic cell nuclear transfer (SCNT) embryos were transferred to 10 recipients. One recipient developed to term and naturally delivered two piglets. The α1,3-galactosyltransferase activity in lung, liver, spleen, and testis of heterozygote α1,3-galactosyltransferase gene knockout (GalT-KO) pigs was significantly decreased, whereas brain and heart showed very low decreasing levels of α1,3-galactosyltransferase activity when compared to those of control. Enzyme-linked lectinosorbent assay showed that the heterozygote GalT-KO pig had more sialylα2,6- and sialylα2,3-linked glycan than the control. Furthermore, the heart, liver, and kidney of the heterozygote GalT-KO pig had a higher N-glycolylneuraminic acid (Neu5Gc) content than the control, whereas the lung of the heterozygote GalT-KO pig had Neu5Gc content similar to the control. Collectively, the data strongly indicated that Neu5Gc is a more critical xenoantigen to overcoming the next acute immune rejection in pig to human xenotransplantation.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22775484 DOI: 10.1089/cell.2011.0083
Source DB: PubMed Journal: Cell Reprogram ISSN: 2152-4971 Impact factor: 1.987